Pseudohypericin is necessary for the light-activated inhibition of prostaglandin E2 pathways by a 4 component system mimicking an Hypericum perforatum fraction

Phytochemistry

Volumn 69, Issue 12, 2008, Pages 2354-2362

  Hammer, Kimberly D P ^a,b   Hillwig, Matthew L ^a,b   Neighbors, Jeffrey D ^a,c   Sim, Young Je ^a,b   Kohut, Marian L ^a,b   Wiemer, David F ^a,c   Wurtele, Eve S ^a,b   Birt, Diane F ^a,b  

^a The Center for Research on Botanical Dietary Supplements   (United States)

^b IOWA STATE UNIVERSITY   (United States)

^c E11 SSH   (United States)

Author keywords

Anti inflammatory; Flavonoids; Guttiferae; Hypericum perforatum; Prostaglandin E2; Pseudohypericin; RAW 264.7

Indexed keywords

ALCOHOL; CHLOROGENIC ACID; DRUG DERIVATIVE; PERYLENE; PLANT EXTRACT; PROSTAGLANDIN E2; PSEUDOHYPERICIN; QUERCETIN; RUTOSIDE;

ANIMAL; ARTICLE; CELL LINE; CHEMISTRY; DRUG EFFECT; HYPERICUM; LIGHT; MACROPHAGE; METABOLISM; MOUSE; PHYSIOLOGY; RADIATION EXPOSURE;

ANIMALS; CELL LINE; CHLOROGENIC ACID; DINOPROSTONE; ETHANOL; HYPERICUM; LIGHT; MACROPHAGES; MICE; PERYLENE; PLANT EXTRACTS; QUERCETIN; RUTIN;

CLUSIACEAE; HYPERICUM PERFORATUM;

EID: 51049087934     PISSN: 00319422     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phytochem.2008.06.010     Document Type: Article

References (35)

1. Aggarwal B.B. Tumour necrosis factor receptor associated signaling molecules and their role in the activation of apoptosis: JNK and NF-kappa B. B. Ann. Rheum. Dis. 59 (2000) 6-16
2. Al-Fayez M., Cai H., Tunstall R., Steward W.P., and Gescher A.J. Differential modulation of cyclooxygenase-mediated prostaglandin production by the putative cancer chemopreventive flavonoids tricin, apigenin, and quercetin. Cancer Chemother. Pharmacol. 58 6 (2006) 816-825
3. Bilia A.R., Gallori S., and Vincieri F.F. St. John's wort and depression: efficacy, safety and tolerability-an update. Life Sci. 70 (2002) 3077-3096
4. Butterweck V., Petereit F., Winterhoff H., and Nahrstedt A. Solubilized hypericin and pseudohypericin from Hypericum perforatum exert antidepressant activity in the forced swimming test. Planta Med. 64 (1998) 291-294
5. Butterweck V., Lieflander-Wulf U., Winterhoff H., and Nahrstedt A. Plasma levels of hypericin in presence of procyanidin B2 and hyperoside: a pharmacokinetic study in rats. Planta Med. 69 (2003) 189-192
6. Calamia K.T. Current and future use of anti-TNF agents in the treatment of autoimmune, inflammatory disorders. Adv. Exp. Med. Biol. 528 (2003) 545-549
7. Carpenter S., and Kraus G.A. Photosensitization is required for inactivation of equine infectious anemia virus by hypericin. Photochem. Photobiol. 53 (1991) 169-174
8. Comalada M., Ballester I., Bailon E., Sierra S., Xaus J., Galvez J., Sanchez de Medina F., and Zarzuelo A. Inhibition of pro-inflammatory markers in primary bone marrow-derived mouse macrophages by naturally occurring flavonoids: analysis of the structure-activity relationship. Biochem. Pharmacol. 72 (2006) 1010-1021
9. Couladis M., Baziou P., Verykokidou E., and Loukis A. Antioxidant activity of polyphenols from Hypericum triquetrifolium Turra. Phytother. Res. 16 (2002) 769-770
10. Deng S., Palu A.K., West B.J., Su C.X., Zhou B.-N., and Jensen J.C. Lipoxygenase inhibitory constituents of the fruits of Noni (Morinda citrifolia) collected in Tahiti. J. Nat. Prod. 70 (2007) 859-862
11. de Waal-Malefyt R., Abrams J., Bennett B., Figdor C.G., and de Vries J.E. Interleukin-10 inhibits cytokine synthesis by human monocytes: an auto-regulatory role of Il-10 produced by monocytes. J. Exp. Med. 174 (1991) 1209-1220
12. Dubois R.N., Abramson S.B., Crofford L., Gupta R.A., Simon L.S., Van De Putte L.B., and Lipsky P.E. Cyclooxygenase in biology and disease. FASEB J. 12 (1998) 1063-1073
13. 2 production by anti-inflammatory Hypericum perforatum extracts and constituents in RAW 264.7 mouse macrophage cells. J. Agric. Food Chem. 55 (2007) 7323-7331
14. Juergenliemk G., and Nahrstedt A. Phenolic compounds from Hypericum perforatum. Planta Med. 68 (2001) 88-91
15. Juergenliemk G., and Nahrstedt A. Dissolution, solubility and cooperativity of phenolic compounds from Hypericum perforatum L. in aqueous systems. Pharmazie 58 (2003) 200-203
16. Juergenliemk G., Boje K., Huewel S., Lohmann C., Galla H.-J., and Nahrstedt A. In vitro studies indicate that miquelianin (quercetin 3-O-β-D-glucuropyranoside) is able to reach the CNS from the small intestine. Planta Med. 69 (2003) 1013-1017
17. Korkina L.G., and Afanasev I.B. Antioxidant and chelating properties of flavonoids. Adv. Pharmacol. 38 (1997) 151-163
18. 2 by quercetin. Inflammation 17 (1993) 573-582
19. Minghetti L., Walsh D.T., Levi G., and Perry V.H. In vivo expression of cyclooxygenase-2 in rat brain following intraparenchymal injection of bacterial endotoxin and inflammatory cytokines. J. Neuropathol. Exp. Neurol. 58 (1999) 1184
20. Miroassay A., Onderkova H., Miroassay L., Sarissky M., and Mojzis J. The effect of quercetin on light-induced cytotoxicity of hypericin. Physiol. Res. 50 (2001) 635-647
21. Murota K., Shimizu S., Chujo H., Moon J.-H., and Terao J. Efficiency of absorption and metabolic conversion of quercetin and its glucosides in human intestinal cell line Caco-2. Biochem. Biophys. 384 (2000) 391-397
22. Niiro H., Otsuka T., Tanabe T., Hara S., Kuga S., Nemoto Y., Tanaka Y., Nakashima H., Kitajima S., Abe M., et al. Inhibition of interleukin-10 of inducible cyclooxygenase expression in lipopolysaccharide-stimulated monocytes: its underlying mechanism in comparison with interleukin-4. Blood 85 (1995) 3736-3745
23. Noeldner M., and Schotz K. Rutin is essential for the antidepressant activity of Hypericum perforatum extracts in the forced swimming test. Planta Med. 68 (2002) 577-580
24. O'Sullivan M.G., Huggins E.M., Meade E.A., DeWitt D.L., and McCall C.E. Lipopolysaccharide induces prostaglandin H synthase-2 in alveolar macrophages. Biochem. Biophys. Res. Commun. 187 (1992) 1123-1127
25. 2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo. J. Exp. Med. 184 (1996) 883-891
26. Przybyszewski J., Yaktine A.L., Duysen E., Blackwood D., Wang W., Au A., and Birt D.F. Inhibition of phorbol ester-induced AP-1-DNA binding, c-Jun protein and c-jun mRNA by dietary energy restriction is reversed by adrenalectomy in SENCAR mouse epidermis. Carcinogenesis 22 (2001) 1421-1427
27. Raso G.M., Pacilio M., Di Carlo G., Esposito E., Pinto L., and Meli R. In-vivo and in-vitro anti-inflammatory effects of Echinacea purpurea and Hypericum perforatum. J. Pharm. Pharmacol. 54 10 (2002) 1379-1383
28. Schmitt L.A., Liu Y., Murphy P.A., and Birt D.F. Evaluation of the light-sensitive cytotoxicity of Hypericum perforatum extracts, fractions, and pure compounds. J. Agric. Food Chem. 54 (2006) 2681-2890
29. Schmitt L.A., Liu Y., Murphy P.A., Petrich J.W., Dixon P.M., and Birt D.F. Reduction in hypericin-induced phototoxicity by Hypericum perforatum extracts and pure compounds. J. Photochem. Photobiol. B 85 2 (2006) 118-130
30. Senchina D.S., McCann D.A., Asp J.M., Johnson J.A., Cunnick J.E., Kaiser M.S., and Kohut M.L. Changes in immunomodulatory properties of Echinacea spp. Root infusions and tinctures stored at 4 °C for four days. Clin. Chim. Acta 355 (2005) 67-82
31. Smith W.L., Garavito R.M., and DeWitt D.L. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J. Biol. Chem. 271 (1996) 33157-33160
32. Snedecor, G.W., Cochran, W.G., 1989. Statistical Methods. Edition 8; Iowa State University Press: Ames, Iowa.
33. Spinella M. The importance of pharmacological synergy in psychoactive herbal medicines. Alt. Med. Rev. 7 2 (2002) 130-137
34. Tournaire C., Croux S., Maurette M.T., Beck I., Hocquaux M., Braun A.M., and Oliveros E. Antioxidant activity of flavonoids: efficiency of singlet oxygen quenching. J. Photochem. Photobiol. B 19 (1993) 205-215
35. Williams F.B., Sander L.C., Wise S.A., and Girard J. Development and evaluation of methods for determination of naphthodianthrones and flavonoids in St. John's wort. J. Chrom. A 1115 (2006) 93-102